Zepp Health Corporation (ZEPP) Misses Q3 EPS by 67c; Offers Guidance

Zepp Health Corporation (NYSE: ZEPP) reported Q3 EPS of RMB0.06, RMB0.67 worse than the analyst estimate of RMB0.73. Revenue for the quarter came in at RMB600 million versus the consensus estimate of RMB1.29 billion.

For the fourth quarter of 2023, the Company\'s management currently expects net revenues to be between RMB600 million and RMB850 million, compared with RMB1.07 billion in the fourth quarter of 2022.

This outlook is based on current market conditions and reflects the Company\'s current and preliminary estimates of market, operating conditions and customer demand, which are all subject to change.

For earnings history and earnings-related data on Zepp Health Corporation (ZEPP) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c